193 related articles for article (PubMed ID: 32464173)
1. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
Lee C; Willerth SM; Nygaard HB
Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
[TBL] [Abstract][Full Text] [Related]
2. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
Marei HE; Khan MUA; Hasan A
Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
[TBL] [Abstract][Full Text] [Related]
3. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
Tcw J
Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
[TBL] [Abstract][Full Text] [Related]
4. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
Mungenast AE; Siegert S; Tsai LH
Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
Yang J; Li S; He XB; Cheng C; Le W
Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
[TBL] [Abstract][Full Text] [Related]
6. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease.
Riemens RJM; Kenis G; van den Beucken T
Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028
[TBL] [Abstract][Full Text] [Related]
7. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
9. [Modeling familial Alzheimer's disease with induced pluripotent stem cells].
Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Okano H; Suzuki N
Rinsho Shinkeigaku; 2012; 52(11):1134-6. PubMed ID: 23196540
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived iPSCs, a reliable
Amponsah AE; Guo R; Kong D; Feng B; He J; Zhang W; Liu X; Du X; Ma Z; Liu B; Ma J; Cui H
Rev Neurosci; 2021 Jun; 32(4):379-402. PubMed ID: 33550785
[TBL] [Abstract][Full Text] [Related]
11. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
12. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
13. Modeling Alzheimer's disease with iPSC-derived brain cells.
Penney J; Ralvenius WT; Tsai LH
Mol Psychiatry; 2020 Jan; 25(1):148-167. PubMed ID: 31391546
[TBL] [Abstract][Full Text] [Related]
14. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
[TBL] [Abstract][Full Text] [Related]
15. A Three-Dimensional Alzheimer's Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1.
Hernández-Sapiéns MA; Reza-Zaldívar EE; Cevallos RR; Márquez-Aguirre AL; Gazarian K; Canales-Aguirre AA
Front Cell Neurosci; 2020; 14():151. PubMed ID: 32655369
[TBL] [Abstract][Full Text] [Related]
16. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
[TBL] [Abstract][Full Text] [Related]
17. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
Si Z; Wang X
J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
[TBL] [Abstract][Full Text] [Related]
18. Modeling familial Alzheimer's disease with induced pluripotent stem cells.
Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Yoshizaki T; Yamanaka S; Okano H; Suzuki N
Hum Mol Genet; 2011 Dec; 20(23):4530-9. PubMed ID: 21900357
[TBL] [Abstract][Full Text] [Related]
19. Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling.
Nair M; Sandhu SS; Sharma AK
Curr Med Chem; 2017; 24(39):4368-4398. PubMed ID: 28748763
[TBL] [Abstract][Full Text] [Related]
20. Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish.
Tong G; Izquierdo P; Raashid RA
Open Neurol J; 2017; 11():27-38. PubMed ID: 29151989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
